2018-2025 Opioids Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 129 pages | ID: 26E60F572DEQEN
QYResearch

Abstracts

SUMMARY

This report studies the Opioids Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Opioids Drug market by product type and application/end industries.

The global Opioids Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Opioids Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Opioids Drug in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Purdue Pharma
• J&J
• Teva
• Mylan
• Depomed
• INSYS
• Endo
• Pfizer
• Hikma
• Mallinckrodt
• Pernix
• Egalet
• Vistapharm

On the basis of product, the market is primarily split into

• Oxycodone
• Hydromorphone
• Codeine
• Fentanyl
• Other

On the basis on the end users/application, this report covers

• Pain Relief
• Anesthesia
• Other

Contents

2018-2025 OPIOIDS DRUG REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 OPIOIDS DRUG MARKET OVERVIEW

2.1 Opioids Drug Product Overview
2.2 Opioids Drug Market Segment by Type
  2.2.1 Oxycodone
  2.2.2 Hydromorphone
  2.2.3 Codeine
  2.2.4 Fentanyl
  2.2.5 Other
2.3 Global Opioids Drug Product Segment by Type
  2.3.1 Global Opioids Drug Sales (K Units) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Opioids Drug Sales (K Units) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Opioids Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Opioids Drug Price (USD/Unit) by Type (2013-2018)
2.4 United States Opioids Drug Product Segment by Type
  2.4.1 United States Opioids Drug Sales (K Units) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Opioids Drug Sales (K Units) and Market Share by Type (2013-2018)
  2.4.3 United States Opioids Drug Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Opioids Drug Price (USD/Unit) by Type (2013-2018)

3 OPIOIDS DRUG APPLICATION/END USERS

3.1 Opioids Drug Segment by Application/End Users
  3.1.1 Pain Relief
  3.1.2 Anesthesia
  3.1.3 Other
3.2 Global Opioids Drug Product Segment by Application
  3.2.1 Global Opioids Drug Sales (K Units) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Opioids Drug Sales (K Units) and Market Share (%) by Application (2013-2018)
3.3 United States Opioids Drug Product Segment by Application
  3.3.1 United States Opioids Drug Sales (K Units) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Opioids Drug Sales (K Units) and Market Share (%) by Application (2013-2018)

4 OPIOIDS DRUG MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Opioids Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Opioids Drug Sales and Revenue by Regions
  4.2.1 Global Opioids Drug Sales (K Units) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Opioids Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  4.2.4 North America Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  4.2.7 South America Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  4.2.9 United States Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

5 GLOBAL OPIOIDS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Opioids Drug Sales (K Units) and Market Share by Players (2013-2018)
5.2 Global Opioids Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Opioids Drug Average Price (USD/Unit) by Players (2013-2018)
5.4 Global Top Players Opioids Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Opioids Drug Market Competitive Situation and Trends
  5.5.1 Opioids Drug Market Concentration Rate
  5.5.2 Global Opioids Drug Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES OPIOIDS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Opioids Drug Sales (K Units) and Market Share by Players (2013-2018)
6.2 United States Opioids Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Opioids Drug Average Price (USD/Unit) by Players (2013-2018)
6.4 United States Opioids Drug Market Share (%) of Top 3 and Top 5 Players

7 OPIOIDS DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Purdue Pharma
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Opioids Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Purdue Pharma Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 J&J
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Opioids Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 J&J Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Teva
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Opioids Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Teva Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Mylan
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Opioids Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Mylan Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Depomed
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Opioids Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Depomed Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 INSYS
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Opioids Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 INSYS Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Endo
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Opioids Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Endo Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Pfizer
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Opioids Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Pfizer Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Hikma
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Opioids Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Hikma Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Mallinckrodt
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Opioids Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Mallinckrodt Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Pernix
7.12 Egalet
7.13 Vistapharm

8 OPIOIDS DRUG MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Opioids Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Opioids Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL OPIOIDS DRUG MARKET FORECAST

10.1 Global Opioids Drug Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
  10.1.1 Global Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Opioids Drug Market Forecast
  10.2.1 United States Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Opioids Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Opioids Drug Forecast by Regions
  10.3.1 North America Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast (2018-2025)
10.4 Opioids Drug Forecast by Type
  10.4.1 Global Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Opioids Drug Sales (K Units) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Opioids Drug Forecast by Application
  10.5.1 Global Opioids Drug Sales (K Units) Forecast by Application (2018-2025)
  10.5.2 United States Opioids Drug Sales (K Units) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Opioids Drug Product Picture
Figure Global Opioids Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Opioids Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Oxycodone
Table Major Players of Oxycodone
Figure Global Oxycodone Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Hydromorphone
Table Major Players of Hydromorphone
Figure Global Hydromorphone Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Codeine
Table Major Players of Codeine
Figure Global Codeine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Fentanyl
Table Major Players of Fentanyl
Figure Global Fentanyl Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Product Picture of Other
Table Major Players of Other
Figure Global Other Sales (K Units) and Growth Rate (%)(2013-2018)
Table Global Opioids Drug Sales (K Units) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Opioids Drug Sales (K Units) by Type (2013-2018)
Table Global Opioids Drug Sales Share (%) by Type (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Type in 2017
Table Global Opioids Drug Revenue (Million USD) by Type (2013-2018)
Table Global Opioids Drug Revenue Share (%) by Type (2013-2018)
Figure Global Opioids Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Opioids Drug Revenue Market Share (%) by Type
Table Global Opioids Drug Price (USD/Unit) by Type (2013-2018)
Table United States Opioids Drug Sales (K Units) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Opioids Drug Sales (K Units) by Type (2013-2018)
Table United States Opioids Drug Sales Share (%) by Type (2013-2018)
Figure United States Opioids Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Opioids Drug Sales Market Share (%) by Type in 2017
Table United States Opioids Drug Revenue (Million USD) by Type (2013-2018)
Table United States Opioids Drug Revenue Share (%) by Type (2013-2018)
Figure United States Opioids Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Opioids Drug Revenue Market Share (%) by Type
Table United States Opioids Drug Price (USD/Unit) by Type (2013-2018)
Figure Pain Relief Examples
Figure Anesthesia Examples
Figure Other Examples
Table Global Opioids Drug Sales (K Units) Comparison by Application (2013-2025)
Table Global Opioids Drug Sales (K Units) by Application (2013-2018)
Table Global Opioids Drug Sales Share (%) by Application (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Application in 2017
Table United States Opioids Drug Sales (K Units) Comparison by Application (2013-2025)
Table United States Opioids Drug Sales (K Units) by Application (2013-2018)
Table United States Opioids Drug Sales Share (%) by Application (2013-2018)
Figure United States Opioids Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Opioids Drug Sales Market Share (%) by Application in 2017
Table Global Opioids Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Opioids Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Opioids Drug Sales (K Units) by Regions (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Opioids Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Opioids Drug Sales Market Share (%) by Regions
Figure 2017 United States Opioids Drug Sales Market Share (%) in Global Market
Table Global Opioids Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Opioids Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Opioids Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Opioids Drug Revenue Market Share (%) by Regions
Figure 2017 United States Opioids Drug Revenue Market Share (%) in Global Market
Table Global Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table North America Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table Europe Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table South America Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table United States Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Table Global Opioids Drug Sales (K Units) of Key Players (2013-2018)
Table Global Opioids Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Opioids Drug Sales Share (%) by Players
Figure 2018 Global Opioids Drug Sales Share (%) by Players
Table Global Opioids Drug Revenue (Million USD) by Players (2013-2018)
Table Global Opioids Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Opioids Drug Revenue Share (%) by Players
Table 2017 Global Opioids Drug Revenue Share (%) by Players
Table Global Market Opioids Drug Average Price (USD/Unit) by Players (2013-2018)
Table Global Opioids Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Opioids Drug Top Players Product Category
Figure Global Opioids Drug Market Share (%) of Top 3 Players
Figure Global Opioids Drug Market Share (%) of Top 5 Players
Table United States Opioids Drug Sales (K Units) by Players (2013-2018)
Table United States Opioids Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Opioids Drug Sales Share (%) by Players
Figure 2018 United States Opioids Drug Sales Share (%) by Players
Table United States Opioids Drug Revenue (Million USD) by Players (2013-2018)
Table United States Opioids Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Opioids Drug Revenue Share (%) by Players
Table 2017 United States Opioids Drug Revenue Share (%) by Players
Table United States Market Opioids Drug Average Price (USD/Unit) by Players (2013-2018)
Figure United States Opioids Drug Market Share (%) of Top 3 Players
Figure United States Opioids Drug Market Share (%) of Top 5 Players
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Purdue Pharma Opioids Drug Sales Growth Rate (2013-2018)
Figure Purdue Pharma Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Purdue Pharma Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table J&J Basic Information List
Table J&J Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure J&J Opioids Drug Sales Growth Rate (2013-2018)
Figure J&J Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure J&J Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Teva Basic Information List
Table Teva Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Teva Opioids Drug Sales Growth Rate (2013-2018)
Figure Teva Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Teva Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Mylan Basic Information List
Table Mylan Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Mylan Opioids Drug Sales Growth Rate (2013-2018)
Figure Mylan Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Mylan Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Depomed Basic Information List
Table Depomed Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Depomed Opioids Drug Sales Growth Rate (2013-2018)
Figure Depomed Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Depomed Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table INSYS Basic Information List
Table INSYS Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure INSYS Opioids Drug Sales Growth Rate (2013-2018)
Figure INSYS Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure INSYS Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Endo Basic Information List
Table Endo Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Endo Opioids Drug Sales Growth Rate (2013-2018)
Figure Endo Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Endo Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Pfizer Basic Information List
Table Pfizer Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Pfizer Opioids Drug Sales Growth Rate (2013-2018)
Figure Pfizer Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Pfizer Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Hikma Basic Information List
Table Hikma Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Hikma Opioids Drug Sales Growth Rate (2013-2018)
Figure Hikma Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Hikma Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Mallinckrodt Opioids Drug Sales Growth Rate (2013-2018)
Figure Mallinckrodt Opioids Drug Sales Global Market Share (%)(2013-2018)
Figure Mallinckrodt Opioids Drug Revenue Global Market Share (%)(2013-2018)
Table Pernix Basic Information List
Table Egalet Basic Information List
Table Vistapharm Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Drug
Figure Opioids Drug Industrial Chain Analysis
Table Major Buyers of Opioids Drug
Table Distributors/Traders List
Figure Global Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Global Opioids Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Opioids DrugOpioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure United States Opioids Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Opioids Drug Sales (K Units) Forecast by Regions (2018-2025)
Figure Global Opioids Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure North America Opioids Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Opioids Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Opioids Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure South America Opioids Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Opioids Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Opioids Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Opioids Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Opioids Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Opioids Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Opioids Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Opioids Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Opioids Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Opioids Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Opioids Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Opioids Drug Sales (K Units) Forecast by Application (2018-2025)
Figure Global Opioids Drug Sales Forecast by Application (2018-2025)
Table United States Opioids Drug Sales (K Units) Forecast by Application (2018-2025)
Figure United States Opioids Drug Sales Forecast by Application (2018-2025)